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Eyes absent (EYA) has tyrosine- and threonine–phosphatase activities in their C-terminal and N-ter-
minal regions, respectively. Using various mutants of mouse EYA3, we showed that the 68-amino
acid domain between positions 53 and 120 was necessary and sufﬁcient for its threonine–phospha-
tase activity. Point mutations were then introduced, and residues Cys-56, Tyr-77, His-79, and Tyr-90
were essential for the EYA3s threonine–phosphatase. The 68-amino acid domain is not well con-
served among the four mouse EYA members, but is evolutionally highly conserved in the ortholo-
gous EYA members of different species, suggesting that the threonine–phosphatase of EYA3 has a
function distinct from that of the other EYAs.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Eyes absent (EYA) was ﬁrst identiﬁed in Drosophila as a tran-
scription co-factor that regulates eye development [1]. In mam-
mals, the EYA family has four members [1]. EYA1, EYA2, and
EYA4 play essential roles in the development of various organs,
such as the ears, kidneys, and muscle [2–4]. In particular, EYA1 is
responsible for a human autosomal dominant disorder called
branchio-oto-renal syndrome (BOR) [5], in which the ears and kid-
neys do not develop properly. In contrast, EYA3-deﬁcient mice,
developed by insertional mutagenesis, show minor phenotypes,
and the physiological roles of EYA3 have not been clear [6].
All EYA familymembers have a conservedhaloacid dehalogenase
(HAD) domain in their C-terminal region [7]. The HAD domain car-
ries tyrosine-phosphatase activity [8–10], and its mutation inacti-
vates EYAs ability to support eye development in Drosophila. The
majority of the missense mutations found in BOR patients are in
the HAD domain of EYA1, suggesting that this domain plays an
important role in the development of this disease [11]. In contrast,
the N-terminal region is not well conserved among the EYA mem-
bers, and has been suggested to serve as a trans-activation domain
[12]. We recently found that the N-terminal region of mouse EYA4
carries threonine–phosphatase [13]. Biochemical properties of thischemical Societies. Published by E
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(S. Nagata).threonine–phosphatase are different from those of the tyrosine-
phosphatase localized to the HAD domain. That is, the tyrosine–
phosphatase has optimal activity under acidic conditions and
requires Mg2+ or Mn2+, whereas the threonine–phosphatase works
under basic conditions and does not require a metal ion. All four
mouse EYA family members show both tyrosine- and threonine–
phosphatase activities, although the speciﬁc activities differ among
the members.
To identify the active site of the EYA threonine–phosphatase,
here we prepared successive N- and C-terminal as well as internal
deletion mutants in mouse EYA3, which has the highest threonine–
phosphatase activity in the mouse EYA family. Phosphatase assays
using these mutants indicated that a 68-amino acid domain from
position 53 to 120 was sufﬁcient for EYA3s threonine–phospha-
tase. By site-directed mutagenesis, residues Cys-56, Tyr-77,
His-79, and Tyr-90 in this domain were shown to be essential for
the threonine–phosphatase activity.
2. Materials and methods
2.1. Production of recombinant EYA3 and EYA4
The coding sequence for the Flag-tag preceded by an ATG codon
and a Kozak sequence was ligated to the coding sequence of mouse
EYA3 or EYA4, and inserted into pEF-BOS-EX or pEU-E01 (Cell Free
Sciences). EYA mutants were produced by recombinant PCR. The
pEF-BOS-EX-based expression vector was expressed in human
293T cells. The transfected cells were lysed at 4 C in lysis buffer
{50 mM Tris–HCl (pH 7.4) containing 1.0% (v/v) Nonidet P-40,lsevier B.V. All rights reserved.
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ml leupeptin, 2.0 lg/ml aprotinin, and2 mM pABSF}. After removing
cell debris, the cell lysateswere loaded onto anti-FlagM2-Sepharose
(Sigma), and the proteinwas elutedwith 50 mMTris–HCl buffer (pH
7.4) containing 150 mM NaCl and 100–500 lg/ml Flag peptide
(Sigma).
EYA3 was also produced using the wheat-germ cell-free system
[14]. Using pEU-E01 based plasmid as a template, EYA3 mRNA was
synthesized using a kit from Cell Free Sciences. EYA protein was
translated from the mRNA by incubation at 15 C for 20 h with
wheat-germ extract and SUB-AMIX (Cell Free Sciences). The reac-
tion mixture was diluted with the lysis buffer, and the EYA3 was
puriﬁed using anti-Flag–Sepharose as above.
2.2. Assay for the phosphatase activity
Puriﬁed EYA were separated by 10–20% SDS–PAGE, stained by
Coomassie Brilliant Blue R250 (CBB), and scanned by LAS4000 (GE
Healthcare). The amount of protein was determined by comparing
the staining intensity of EYA with that of BSA standards using Mul-
ti-Gauge version 3.2 (Fujiﬁlm) software. The phosphatase was
assayed as described [13]. In brief, phosphorylated peptides
SDQEKRKQI(pT)VRGL and RRLIEDAE(pY)AARG were custom-
synthesized byMBL. EYAwas incubated in 50 ll with 400 lMphos-
phorylated peptide at 37 C for 60 min in 50 mM MES–KOH buffer
(pH 6.0) containing 2 mM MgCl2 and 1 mM DTT for the tyrosine-
phosphatase, or in 50 mM Tricine–KOH buffer (pH 8.0) containing
5 mM EDTA and 1 mM DTT for the threonine–phosphatase. To stop
the reaction, 50 ll of H2O and 20 ll of 6 N H2SO4 containing 1.75%
(w/v) ammonium heptamolybdate tetrahydrate (Fluka) was added,
and incubatedat roomtemperature for 20 min. Then, 20 ll of 0.035%
(w/v) malachite green oxalate (Merck) and 0.35% (w/v) polyvinylal-
chol (Typical Mw 13 000–23 000) (Sigma) was added, and further
incubated for 20 min. The malachite green-ammonium molybdate
phosphate complex was detected at 620 nm using a Micro Plate
reader (BioLumin 960).Fig. 1. C-terminal and N-terminal deletion mutants of the EYA3 threonine–phosphatase
N-terminal (D) deletion mutants. Numbers indicate the amino acid position at the C-term
domain of EYA3 for the threonine–phosphatase. (B and E) The puriﬁed EYA3 2–256 and
weight standards (in kDa) are shown at left. (C and F) The threonine–phosphatase activ3. Results
3.1. N-terminal and C-terminal deletion mutants in mouse EYA3
We previously showed that the N-terminal region of mouse EYA
family members carries threonine–phosphatase activity [13]. The
threonine–phosphatase activity of EYA3 had the highest speciﬁc
activity, at least 3–48-times that of the other EYA members [13].
To determine the domain essential for the threonine–phosphatase,
N- and C-terminal deletion mutants were prepared for the N-
terminal region (amino acid position 2–256) of EYA3.
We designed deletion mutants using the knowledge that each
exon codes for a functional unit or domain [15]. Since EYA3 2–256
is encoded by 8 exons (exons 2–9), its C-terminal deletion mutants
were prepared by successively deleting the region corresponding
to exon 9, 8–9, 7–9, and 6–9 (Fig. 1A). The resultingmutants (amino
acid positions 2–210, 2–149, 2–120, and 2–75) were tagged with
Flag-peptide and expressed in human 293T cells. Except for the 2–
75 mutants, the puriﬁed proteins were of the expected size on
SDS–PAGE (Fig. 1B). The acidic nature of the 2–75 mutants, which
contained 15 acidic amino acids and 6 basic amino acids, may
explain its abnormal movement on SDS–PAGE. The assay for
the threonine–phosphatase indicated that EYA3 2–256 efﬁciently
de-phosphorylated the phospho-threonine peptide (Km: 178.8 lM,
and Kcat: 59.4 min1) (Fig. 1C and Table 1). The mutants 2–149 and
2–120 showed the phosphatase activity comparable to EYA3 2–
256, while the C-terminal deletion to position 75 caused the com-
plete loss of the activity. That is, its Kcat/Km value went down to an
undetectable level (Table 1). These results indicated that the threo-
nine–phosphatase activity of mouse EYA3 is in amino acid positions
2–120.
TheN-terminal deletionmutantswere then prepared by deleting
the region corresponding to exon 2, 2–3, 2–4, 2–5, and 2–6 (Fig. 1D).
The mutant proteins (EYA3 2–256, 12–256, 27–256, 53–256, 76–
256, and 121–256) were produced and puriﬁed (Fig. 1E). The mu-
tants 12–256, 27–256 and 53–256 efﬁciently de-phosphorylateddomain. (A and D) Schematic representation of EYA3 2–256, its C-terminal (A), and
inal or N-terminal deletion end. The black and green areas indicate Flag-tag and the
its mutants (0.1 lg) were analyzed by SDS–PAGE, and stained with CBB. Molecular
ity was determined using the indicated amounts of EYA3.
Table 1
Kinetic constants for the threonine–phosphatase activity of the wild-type and mutant mouse EYA3.
Flag mEYA3 Km (lM) Kcat (min1) Kcat/Km (lM/min1) Relative Kcat/Km (%)
EYA3 2–256 178.8 59.39 0.332 100.0
EYA3 2–210 172.4 54.48 0.316 95.2
EYA3 2–149 179.8 42.40 0.236 71.1
EYA3 2–120 132.5 39.54 0.298 89.8
EYA3 2–75 493.4 0.30 <0.001 <0.3
EYA3 12–256 187.6 30.07 0.160 48.2
EYA3 27–256 163.1 43.64 0.268 80.7
EYA3 53–256 167.8 41.21 0.246 74.1
EYA3 76–256 275.0 4.07 0.015 4.5
EYA3 121–256 423.0 1.92 0.004 1.2
EYA3 WT 167.4 77.05 0.460 100.0
EYA3 D53–75 322.2 5.29 0.016 3.5
EYA3 D76–120 518.8 3.26 0.006 1.3
EYA3 D121–149 273.9 95.23 0.348 75.7
EYA3 D150–210 256.3 78.40 0.306 66.5
EYA3 C56A 164.1 17.36 0.106 23.0
EYA3 Y77A 192.8 14.85 0.077 16.7
EYA3 H79A 400.8 7.71 0.019 4.1
EYA3 Y90A 127.3 17.35 0.136 29.6
The threonine–phosphatase activity of the N-terminal region of mouse EYA3 (EYA3 2–256) and its mutants, and the wild-type full
length mouse EYA3 and its mutants were assayed with SDQEKRKQI(pT)VRGL as a substrate. The Km and Kcat values were determined
using Hanes–Woolf plot [20]. In ‘‘relative Kcat/Km’’ column, the Kcat/Km value is expressed as percentage of that of the EYA3 2–256 or the
full-length wild-type EYA3.
Fig. 2. The threonine–phosphatase activity of EYA3 and its internal deletion mutants. (A) Schematic representation of the full-length EYA3 (EYA3 FL), and its internal deletion
mutants. Numbers above the ﬁrst column indicate the amino acid position at which each internal deletion ends. (B) The puriﬁed EYA3 (0.15 lg) were analyzed by SDS–PAGE,
and stained with CBB. (C and D) Using 0.5 (C) or 2.5 (D) pmoles of EYA3, the threonine- (C) or tyrosine- (D) phosphatase was assayed.
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terminal 52 amino acids were dispensable for EYA3s threonine–
phosphatase activity. On the other hand, the mutants 76–256 and
121–256 lostmost of the phosphatase activity, and theirKcat/Kmval-
ues were 1.2–4.5% of the EYA3 2–256 (Table 1). These results indi-
cated that the threonine–phosphatase activity is in amino acid
positions 53–256.
3.2. A minimum domain for EYA3s threonine–phosphatase activity
The above results with the N-terminal and C-terminal deletion
mutants indicated that the domain from amino acids 53–120 wasessential for EYA3s threonine–phosphatase. To conﬁrm this,
internal deletion mutants of full-length mouse EYA3 were
constructed (Fig. 2A), produced in 293T cells, and afﬁnity-puriﬁed
(Fig. 2B). As shown in Fig. 2C, the deletion of amino acids 121–
149 or 150–210 had no effect on the threonine–phosphatase
activity (Fig. 2C, Table 1). But, the deletion of amino acids 53–
75 or 76–120 caused loss of the threonine–phosphatase activity.
That is, Kcat/Km values of these internal mutants went down
to 1.3–3.5% of the wild-type EYA3 (Table 1). All the mutants
showed similar tyrosine-phosphatase activity, conﬁrming that
the threonine- and tyrosine-phosphatase activities of EYA3 were
independent.
Fig. 3. Identiﬁcation of the EYA3 domain sufﬁcient for the threonine–phosphatase. (A) Schematic representation of EYA3 2–256, and the minimal domain for EYA3s
threonine–phosphatase (53–120). Recombinant proteins were tagged with Flag at N-terminus (black area). The region from amino acids 53–120 is in green. (B) Proteins
produced by a cell-free system, and afﬁnity-puriﬁed. Aliquots (0.1 lg) were separated by SDS–PAGE, and stained with CBB. (C) Using the indicated amounts of the puriﬁed
EYA3, the threonine–phosphatase activity was determined.
Fig. 4. Point mutations in the EYA3 threonine–phosphatase domain. (A) The amino acid sequence of mouse EYA3 from positions 53 to 120 was aligned with the
corresponding region of mouse EYA1, EYA2, and EYA4 by introducing gaps (–). Residues [glutamine (Q), lysine (K), and tyrosine (Y)] conserved in mouse EYA family are in
blue, and the amino acids mutated to alanine in EYA3 are in red. In some cases, two tyrosine residues were mutated in one construct. (B) EYA3 were produced in 293T cells,
and puriﬁed. Aliquots (0.1 lg) was separated by SDS–PAGE, and stained with CBB. (C) Using 0.5 pmol of EYA3, the threonine phosphatase was assayed, and is expressed as
percentage of the wild-type. (D) Evolutional conservation of the threonine–phosphatase domain in EYA3. The EYA3 amino acid sequence for the threonine–phosphatase from
various animals was aligned. Numbers above the ﬁrst line indicate the amino acid position of mouse EYA3. Essential amino acids for the threonine–phosphatase of mouse
EYA3 are indicated in red. The amino acid residues that are different from mouse EYA3 are underlined.
T. Sano, S. Nagata / FEBS Letters 585 (2011) 2714–2719 2717To examine whether the domain of amino acid 53–120 is sufﬁ-
cient for the EYA3 threonine–phosphatase, this region was ex-
pressed in a cell-free system using wheat-germ extract. As
shown in Fig. 3, the polypeptide of EYA3 53–120, with a Mr. of
11 kDa, had dose-dependent threonine–phosphatase activity.3.3. Assignment of the active-site amino acids in EYA3s threonine–
phosphatase
Cysteine, arginine, lysine, aspartic acid, and histidine residues of-
ten serveas active residues for variousphosphatases [16,17]. The68-
Fig. 5. The threonine–phosphatase activity of mouse EYA4 and its internal deletion
mutants. (A) A schematic representation of the full-length EYA4 (EYA4 WT), and its
internal deletion mutants. Numbers above the ﬁrst column indicate the amino acid
position at which each internal deletion starts. (B) The puriﬁed EYA4 (0.1 lg) were
analyzed by SDS–PAGE, and stained with CBB. (C) Using 1.0 pmol of EYA4, the
threonine–phosphatase was assayed. (D) The relative threonine–phosphatase
activity of each internal deletion mutant was compared between EYA3 and EYA4.
The domains A, B, and C represent the region of amino acid 53–75, 76–120, and
150–210 of EYA3, and 100–123, 124–170, and 246–300 of EYA4, respectively. The
phosphatase activity of EYA3 is from Fig. 2C, and EYA4s activity is from Fig. 5C. The
activity of each mutant is expressed as percentage of the wild-type EYA3 or EYA4.
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tase activity contains one residue each of lysine, cysteine, histidine,
andarginine, and twoof aspartic acid (Fig. 4A). In addition, nine tyro-
sine residues in the domain are conserved among the mouse EYA
family members. To determine the active-site residues for the thre-
onine–phosphatase, pointmutationswere introduced intoEYA353–
120 singly or doubly at all these residues (15 residues) by replacing
the residue with alanine (Fig. 4A). The preliminary analysis showed
that themutationsatCys-56,His-79,Tyr-72/Tyr-77, andTyr-90/Tyr-
96 severely reduced its phosphatase activity (data not shown). Sin-
gle or double mutations were then introduced into the full-length
EYA3 at residues of Cys-56, Tyr-72, Tyr-77, His-79, Tyr-90, Tyr-96,
aswell as Asp-58 andAsp-66. The resultingmutantswere expressed
in 293T cells and puriﬁed (Fig. 4B). As shown in Fig. 4C and Table 1,
the singlemutation at His-79 caused an increase of Kmvalue, and re-
duced the Kcat/Km value to 4.1% of thewild-type EYA3. Themutation
at Tyr-77 and Tyr-90 also signiﬁcantly inactivated the phosphatase,
and their Kcat/Km values were 20–30% of the wild-type EYA3 (Table
1). These results indicated that Cys-56, Tyr-77, His-79, and Tyr-90
are part of the active site for EYA3s threonine–phosphatase. In par-
ticular, His-79 may be involved in the substrate binding.
4. Discussion
We showed here that a 68-amino acid region of mouse EYA3
extending from position 53 to 120 is necessary and sufﬁcient forits threonine–phosphatase activity. Further analysis of point muta-
tions in this region revealed that residues Cys-56, Tyr-77, His-79,
and Tyr-90 are essential for the threonine–phosphatase. Cysteine,
histidine, and tyrosine residues are often present in the active site
of various phosphatases; they are used to recognize the phosphate
on phosphorylated proteins and catalyze its hydrolysis [18]. The
essential role of these residues indicates that the threonine–phos-
phatase activity is an intrinsic property of EYA3.
The human and mouse EYA families both consist of four mem-
bers [1]. The 271 amino acid C-terminal HAD domain containing
the tyrosine-phosphatase is well conserved among the EYA mem-
bers (68.6–76.0% identity among the four mouse EYA members).
On the other hand, the N-terminal domain is less well conserved
among the members (Fig. 4A). The amino acid identity of the
68-amino acid region containing the threonine–phosphatase
activity is 29–36.8% among them. In particular, the cysteine
residue corresponding to Cys-56 in EYA3 that is essential for the
threonine–phosphatase is missing in the other members, and
His-79 in EYA3 is replaced by tyrosine in EYA2. This divergence
of the amino acid sequence may explain the more than 40-fold
difference in the speciﬁc activity of the threonine–phosphatase
among mouse EYA members [13].
We previously showed that mutations of four tyrosine residues
cause the loss of threonine–phosphatase activity in mouse EYA4
[13]. The region where the four tyrosine-residues are present is dif-
ferent from the domain that is essential for the phosphatase activity
of mouse EYA3. However, a study of internal deletion mutants of
EYA4 indicated that not only the domain of amino acids
246–300 (domain C), but also the domain of amino acids 124–170
(domain B) that corresponds to the region of amino acids 76–120
of EYA3 contributes to its threonine phosphatase activity (Fig. 5).
It is possible that EYA3 evolved to acquire strong phosphates activ-
ity by changing the amino acid sequence in the region from 53–120
(domain A and B, in Fig. 5). An analysis of the tertiary structure of
the N-terminal region of EYA3 and EYA4 will be necessary to deﬁne
the mechanism of the EYAs threonine–phosphatase activity.
In contrast to the low similarity among the EYA family mem-
bers in mouse, the N-terminal region is well conserved evolution-
arily among the EYA3 members of different species in vertebrates.
The 68-amino acid threonine–phosphatase region of EYA3 has an
identity of 97.1–100% among mammals (Fig. 4D). Even in Xenopus,
this region has 76.5% identity with the corresponding region of
mouse EYA3. In particular, the Cys-56, Tyr-77, His-79, and Tyr-90
residues are conserved in mammals, chicken and Xenopus. This
N-terminal region is also conserved among orthologues of the
other members of the EYA family: the identity of the correspond-
ing sequences of EYA1, EYA2, and EYA4 of mouse and human is
93.0%, 84.1%, and 97.1%, respectively. This observation, together
with the low similarity of this region among different EYA family
members, suggests that the N-terminal region of each EYAmember
has a distinct function. We previously reported that the threonine–
phosphatase of mouse EYA4 regulates the nucleic-acid-triggered
innate immune reaction. Compared with EYA4, this activity of
EYA3 was weak (T.S, and S.N., unpublished observation). On the
other hand, EYA3 is reported to regulate the survival and prolifer-
ation of neural progenitor cells in the anterior neural plate of
Xenopus embryos [19]. Inactivation of the tyrosine-phosphatase
in the HAD domain does not diminish EYA3s ability to stimulate
the survival and proliferation of these cells. It will be interesting
to examine whether EYA3s threonine–phosphatase is involved in
its ability to stimulate neural cell proliferation in Xenopus. Mouse
EYA3 is expressed in the liver, heart, brain, skin, and salivary
glands (T.S., and S.N., unpublished results). The null mutation of
EYA3 has weak effects on respiratory, heart, and muscle function
[6]. Whether these effects are due to the lack of tyrosine- or thre-
onine–phosphatase remains to be studied.
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